Recruiting NA Breast Cancer

New treatment option for Breast Cancer

Official title Airwave Compression Therapy to Prevent Breast Cancer-related Lymphedema

ClinicalTrials.gov ID: NCT06495034

What this study is testing

What it's testing
This study aims to explore the effectiveness of early intervention of airwave compression therapy to prevent the occurrence of postoperative breast cancer-related lymphedema(BCRL).

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 70, women only

You may be able to join if

  • Volunteer to participate in this clinical trial. Fully understand and be informed about the study and sign an informed consent form (ICF). Willing to...
  • Female, ≥18 years old and ≤70 years old at the time of signing the ICF;
  • Patients with unilateral breast cancer diagnosed by histopathology or cytology;
  • No distant metastasis;
  • To undergo unilateral axillary sentinel lymph node biopsy or unilateral axillary lymph node dissection;

You likely can't join if

  • Breast malignancy derived from other tumors rather than the primary breast cancer;
  • Patients with second primary tumor;
  • Contraindication to airwave compression therapy: Acute venous thrombosis; Acute inflammatory skin disease; Erysipelas; Arrhythmia; Pulmonary edema...
  • Have a history of mental illness or other reasons can not cooperate with treatment;
  • Embolism, cardiogenic edema, hepatogenic edema and the history of upper limb trauma and other related complications;
  • Patients using any medication that affects fluid or electrolyte balance.
See the full eligibility criteria
Who can join
  • Volunteer to participate in this clinical trial. Fully understand and be informed about the study and sign an informed consent form (ICF). Willing to follow and able to complete all test procedures;
  • Female, ≥18 years old and ≤70 years old at the time of signing the ICF;
  • Patients with unilateral breast cancer diagnosed by histopathology or cytology;
  • No distant metastasis;
  • To undergo unilateral axillary sentinel lymph node biopsy or unilateral axillary lymph node dissection;
  • Have not received any treatment for arm lymphedema;
  • No lymphangitis and other infections.
What rules you out
  • Breast malignancy derived from other tumors rather than the primary breast cancer;
  • Patients with second primary tumor;
  • Contraindication to airwave compression therapy: Acute venous thrombosis; Acute inflammatory skin disease; Erysipelas; Arrhythmia; Pulmonary edema; Unstable hypertension; People with artificial pacemakers; Deep...
  • Have a history of mental illness or other reasons can not cooperate with treatment;
  • Embolism, cardiogenic edema, hepatogenic edema and the history of upper limb trauma and other related complications;
  • Patients using any medication that affects fluid or electrolyte balance.

The study team makes the final eligibility decision.

Where it's taking place

  • Shantou, Guangdong, China

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, 18 years to 70 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Shantou, Guangdong, China. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.